Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vives

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Journal of Hematology & Oncology|July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemiaE Genescà, A Lazarenkov, M Morgades, et al.
Annals of Hematology|June 17, 2024
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?E U Suárez, B Boluda, E Lavilla, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Journal of Hematology & Oncology|July 26, 2018
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemiaE Genescà, A Lazarenkov, M Morgades, et al.
Annals of Hematology|June 17, 2024
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?E U Suárez, B Boluda, E Lavilla, et al.
Pageof 3